gabexate has been researched along with Biliary Atresia in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Biliary Atresia: Progressive destruction or the absence of all or part of the extrahepatic BILE DUCTS, resulting in the complete obstruction of BILE flow. Usually, biliary atresia is found in infants and accounts for one third of the neonatal cholestatic JAUNDICE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamada, Y | 1 |
| Hoshino, K | 1 |
| Morikawa, Y | 1 |
| Okamura, J | 1 |
| Hotta, R | 1 |
| Komori, K | 1 |
| Nakao, S | 1 |
| Obara, H | 1 |
| Kawachi, S | 1 |
| Fuchimoto, Y | 1 |
| Tanabe, M | 1 |
| Shimazu, M | 1 |
| Kitajima, M | 1 |
1 other study available for gabexate and Biliary Atresia
| Article | Year |
|---|---|
Successful liver transplantation across the ABO incompatibility barrier in 6 cases of biliary atresia.
Topics: ABO Blood-Group System; Adolescent; Adult; Alprostadil; Biliary Atresia; Child; Clinical Protocols; | 2006 |